Stock DDPN DUPONT DE NEMOURS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings DuPont de Nemours, Inc. Wiener Boerse

Equities

DDPN

US26614N1028

End-of-day quote Wiener Boerse
Other stock markets
 03:30:00 14/06/2024 am IST 		5-day change 1st Jan Change
74.53 EUR +0.65% Intraday chart for DuPont de Nemours, Inc. +0.69% +7.02%
13/06 DuPont Launches New Tedlar® Frontsheet Offerings At 2024 Snec Pv Power Expo CI
07/06 Declaration of Voting Results by DuPont de Nemours, Inc CI

Summary

  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
  • For the past twelve months, EPS forecast has been revised upwards.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
  • The opinion of analysts covering the stock has improved over the past four months.
  • Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.

Weaknesses

  • With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
  • The company benefits from high valuations in earnings multiples.
  • With an enterprise value anticipated at 3.15 times the sales for the current fiscal year, the company turns out to be overvalued.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Diversified Chemicals

1st Jan change Capi. Investor Rating ESG Refinitiv
DUPONT DE NEMOURS, INC. Stock DuPont de Nemours, Inc.
+7.02% 33.31B -
SHIN-ETSU CHEMICAL CO., LTD. Stock Shin-Etsu Chemical Co., Ltd.
+3.85% 77.9B
B
BASF SE Stock BASF SE
-8.60% 42.56B
A-
PIDILITE INDUSTRIES LIMITED Stock Pidilite Industries Limited
+14.54% 18.93B
B
EASTMAN CHEMICAL COMPANY Stock Eastman Chemical Company
+10.79% 11.7B
A-
BRENNTAG SE Stock Brenntag SE
-21.89% 10.04B
B
SYENSQO SA/NV Stock Syensqo SA/NV
-6.29% 9.94B -
ASAHI KASEI CORPORATION Stock Asahi Kasei Corporation
-2.89% 8.89B
A-
SRF LIMITED Stock SRF Limited
-3.12% 8.53B
C-
MITSUBISHI CHEMICAL GROUP CORPORATION Stock Mitsubishi Chemical Group Corporation
-5.64% 7.37B
B
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. DD Stock
  4. DDPN Stock
  5. Ratings DuPont de Nemours, Inc.